Alkem

{{ Form::open(['url' => '#', 'name' => 'validateForm', 'id' => 'validateForm', 'enctype' => 'multipart/form-data']) }} @csrf

Back

Effectiveness and Safety of Telmisartan and Amlodipine Combination in Patients with Hypertension: A Retrospective Study

BASIC DETAILS

Patient code (Do not write name here) *

Date *

Diagnosis : Newly Diagnosed mild to moderate hypertension

Patient's Age (years) *

Gender *

Male Female

Weight (in Kg) *

Obesity (BMI) *

Underweight (<18.5 kg/m²) Normal BMI (18.5-22.9 kg/m²) Over weight (23.0 -24.9 kg/m²) Obese (>25 kg/m²)

Active Smoker *

Yes No

Alcohol *

Yes No

Tobacco use *

Yes No

Family history of dyslipidemia *

Yes No

Dose of Telmisartan + Amlodipine *

Telmisartan + Amlodipine (20/5 mg) Telmisartan + Amlodipine (40/5 mg) Telmisartan + Amlodipine (80/5 mg)

Examinations and investigations *

Parameter	Baseline	Observation after 3 months
Systolic BP
Diastolic BP

Adverse events *

Yes No

@include('user.footer')